Comprehensive Analysis of Peripheral Blood Lymphocytes in 76 Women with Recurrent Miscarriage before and after Lymphocyte Immunotherapy

American Journal of Reproductive Immunology

Volumn 68, Issue 2, 2012, Pages 164-174

  Liang, Peiyan ^a,b   Mo, Meilan ^a,b   Li, Guan Gui ^a,b   Yin, Biao ^a,b   Cai, Jing ^a,b   Wu, Tonghua ^a,b   He, Xuebing ^a,b   Zhang, Xu ^a,b   Zeng, Yong ^a,b  

^a Shenzhen Zhongshan Urological Hospital   (China)

^b Shenzhen Zhongshan Institute for Reproductive Medicine and Genetics   (China)

Author keywords

Immunophenotype; Lymphocyte immunotherapy; NK cytotoxicity; Recurrent miscarriage; Th1 Th2 ratio

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD69 ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL EVALUATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; GESTATIONAL AGE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; IMMUNOTHERAPY; LUTEAL PHASE; LYMPHOCYTE IMMUNOTHERAPY; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PERIPHERAL LYMPHOCYTE; PREGNANCY; PRIORITY JOURNAL; RECURRENT ABORTION; TH1 CELL; TH2 CELL;

ABORTION, HABITUAL; ADULT; ANTIGENS, CD; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOPHENOTYPING; IMMUNOTHERAPY, ADOPTIVE; INTERFERON-GAMMA; INTERLEUKIN-10; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH1-TH2 BALANCE;

EID: 84863877738     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2012.01141.x     Document Type: Article

References (41)

1. Mills J, Driscoll S, Jovanovic-Peterson L, Van Allen M, Aarous JH, Metzger B: Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. New Engl J Med 1988; 319:1617-1623.
2. Regan L, Rai R: Epidemiology and the medical cause of miscarriage. Bailliere's Clin Obstet Gynaecol 2000; 14:839-854.
3. Choudhury SR, KnappHuman LA: Reproductive failure I: Immunological factors. Hum Reprod Update 2001; 7:113-134.
4. Porter TF, LaCoursiere Y, Scott JR: Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev 2006; 19:1-23.
5. Kishore R, Agrawal S, Halder A, Das V, Shukla BR: HLA sharing, anti-paternal cytotoxic antibodies and MLR blocking factors in women with recurrent spontaneous abortion. J Obstet Gynaecol Res 1996; 22:177-183.
6. von Landenberg P, Matthias T, Zaech J, Schultz M, Lorber M, Blank M, Shoenfeld Y: Antiprothrombin antibodies are associated with pregnancy loss in patients with the antiphospholipid syndrome. Am J Reprod lmmunol 2003; 49:51-56.
7. Raghupathy R, Makhseed M, Azizieh F, Omu A, Gupta M, Farhat R: Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum Reprod 2000; 15:713-718.
8. + cells in peripheral blood lymphocytes in pregnant women with recurrent pregnancy losses. Am J Reprod Immunol 1995; 34:93-99.
9. Yamada H, Kato EH, Kobashi G, Ebina Y, Shimada S, Morikawa M, Sakuragi N, Fujimoto S: High NK cell activity in early pregnancy correlates with subsequent abortion with normal chromosomes in women with recurrent abortion. Am J Reprod Immunol 2001; 46:132-136.
10. Pandey MK, Agrawal S: Induction of MLR-Bf and protection of fetal loss: a current double blind randomized trial of paternal lymphocyte immunization for women with recurrent spontaneous abortion. Int Immunopharmacol 2004; 4:289-298.
11. Nonaka T, Takakuwa K, Ooki I, Akashi M, Yokoo T, Kikuchi A, Tanaka K: Results of immunotherapy for patients with unexplained primary recurrent abortions-prospective non-randomized cohort study. Am J Reprod Immunol 2007; 58:530-536.
12. Clark DA: Immunological factors in pregnancy wastage: Fact or Fiction. Am J Reprod Immunol 2008; 59:277-300.
13. Check JH, Arwitz M, Gross J, Peymer M, Szekeres-Bartho J: Lymphocyte immunotherapy (LI) increases serum levels of progesterone induced blocking factor (PIBF). Am J Reprod Immunol 1997; 37:17-20.
14. Ho HN, Gill III TJ, Hsieh HJ, Jiang JJ, Lee TY, Hsieh CY: Immunotherapy for recurrent spontaneous abortion in a Chinese population. Am J Reprod Immunol 1991; 25:10-15.
15. Illeni MT, Marelli G, Parazzini F, Acaia B, Bocciolone L, Bontempelli M, Faden D, Fedele L, Maffeis A, Radici E: Immunotherapy and recurrent abortion: a randomized clinical trial. Hum Reprod 1994; 9:1247-1249.
16. Ober C, Karrison T, Odem RR, Barnes RB, Branch DW, Stephenson MD, Baron B, Walker MA, Scott JR, Schreiber JR: Mononuclear-cell immunisation in prevention of recurrent miscarriages: a randomised trial. Lancet 1999; 354:365-369.
17. Stephensen MD: Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril 1996; 66:24-29.
18. Malinowski A, Wilczynski J, Zeman K, Glowacka E, Kolasa D, Szpakowski A, Oszukowski P, Szpakowski M: Immunological characteristics of nonpregnant women with unexplained recurrent spontaneous abortion who underwent paternal lymphocytes immunization. Zentralbl Gynakol 1998; 120:493-502.
19. Yokoo T, Takakuwa K, Ooki I, Kikuchi A, Tamura M, Tanaka K: Alteration of TH1 and TH2 cells by intracellular cytokine detection in patients with unexplained recurrent abortion before and after immunotherapy with the husband's mononuclear cells. Fertil Steril 2006; 85:1452-1458.
20. Pandey MK, Thakur S, Agrawal S: Lymphocyte immunotherapy and its probable mechanism in the maintenance of pregnancy in women with recurrent spontaneous abortion. Arch Gynecol Obstet 2004; 269:161-172.
21. Prado-Drayer A, Teppa J, Sánchez P, Camejo MI: Immunophenotype of peripheral T lymphocytes, NK cells and expression of CD69 activation marker in patients with recurrent spontaneous abortions, during the mid-luteal phase. Am J Reprod Immunol 2008; 60:66-74.
22. Szpakowski A, Malinowski A, Cieslak J, Nowak M, Wilczynski JR, Banasik M, Szpakowski M, Tchórzewski H: Influence of paternal lymphocyte immunization on the selected subpopulations of peripheral blood lymphocytes in women with recurrent spontaneous abortions of unknown etiology. Ginekol Pol 2003; 74:288-296.
23. Jablonowska B, Palfi M, Matthiesen L, Selbing A, Kjellberg S, Ernerudh J: T and B Lymphocyte subsets in patients with unexplained recurrent spontaneous abortion: IVIG versus placebo treatment. Am J Reprod Immunol 2002; 48:312-318.
24. Darmochwal-Kolarz D, Leszczynska-Gorzelak B, Rolinski J, Oleszczuk J: The immunophenotype of patients with recurrent pregnancy loss. Eur J Obstet Gynecol Reprod Biol 2002; 103:53-57.
25. Kwak-Kim J, Gilman-Sachs A: Clinical implication of natural killer cells and reproduction. Am J Reprod Immunol 2008; 59:388-400.
26. Hussain MJ, Alviggi L, Millward BA: Evidence that the reduced number of natural killer cells in type 1 (insulindependent) diabetes may be genetically determined. Diabetologia 1987; 30:907-911.
27. Higuchi K, Aoki K, Kimbara T, Hosoi N, Yamamoto T, Okada H: Suppression of natural killer cell activity by monocytes following immunotherapy for recurrent spontaneous aborters. Am J Reprod Immunol 1995; 33:221-227.
28. King K, Smith S, Chapman M, Sacks G: Detailed analysis of peripheral blood natural killer (NK) cells in women with recurrent miscarriage. Hum Reprod 2010; 25:52-58.
29. Aoki K, Kajiura S, Matsumoto Y, Ogasawara M, Okada S, Yagami Y, Gleicher N: Preconceptional natural-killer-cell activity as a predictor of miscarriage. Lancet 1995; 345:1340-1342.
30. Coulam CB, Goodman C, Roussev RG, Thomason EJ, Beaman KD: Systemic CD56+ cells can predict pregnancy outcome. Am J Reprod Immunol 1995; 33:40-46.
31. Saini V, Arora S, Yadav A, Bhattacharjee J: Cytokines in recurrent pregnancy loss. Clin Chim Acta 2011; 412:702-708.
32. Burns WR, Wang Y, Tang PC, Ranjbaran H, Iakimov A, Kim J, Cuffy M, Bai Y, Pober JS, Tellides G: Recruitment of CXCR3 + and CCR5 + T cells and production of interferon-gamma-inducible chemokines in rejecting human arteries. Am J Transplant 2005; 5:1226-1236.
33. Li XC, Zand MS, Li Y, Zheng XX, Strom TB: On histocompatibility barriers, Th1 to Th2 immune deviation, and the nature of the allograft responses. J Immunol 1998; 161:2241-2247.
34. Raghupathy R: Th1-type immunity is incompatible with successful pregnancy. Immunol Today 1997; 10:478-482.
35. Gharesi-Fard B, Zolghadri J, Kamali-Sarvestani E: Effect of leukocyte therapy on tumor necrosis factor-alpha and interferon-gamma production in patients with recurrent spontaneous abortion. Am J Reprod Immunol 2008; 59:242-250.
36. Kwak-Kim JY, Chung-Bang HS, Ng SC, Ntrivalas EI, Mangubat CP, Beaman KD, Beer AE, Gilman-Sachs A: Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod 2003; 18:767-773.
37. Moreau P, Adrian-Cabestre F, Menier C, Guiard V, Gourand L, Dausset J, Carosella ED, Paul P: IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int Immunol 1999; 11:803-811.
38. Hayakawa S, Karasaki-suzuki M, Itoh T, Ishii M, Kanaeda T, Nagai N, Takahashi-yamamoto N, Tochigi M, Chishima F, Fujii KT, Oyama J, Kitanaka S, Satoh K: Effects of paternal lymphocyte immunization on peripheral Th1/Th2 balance and TCR Vβ and Vγ repertoire usage of patients with recurrent spontaneous abortions. Am J Reprod Immunol 2000; 43:107-114.
39. Saito S, Sakai M, Sasaki Y, Tanebe K, Tsuda H, Michimata T: Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin Exp Immunol 1999; 117:550-555.
40. Makhseed M, Raghupathy R, Azizieh F, Omu A, Al-Shamali E, Ashkanani L: Th1 and Th2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions. Hum Reprod 2001; 16:2219-2226.
41. Kheshtchin N, Gharagozloo M, Andalib A, Ghahiri A, Maracy MR, Rezaei A: The expression of Th1- and Th2-Related chemokine receptors in women with recurrent miscarriage: the impact of lymphocyte Immunotherapy. Am J Reprod Immunol 2010; 64:104-112.